Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

Clinical trial NCT07541703 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07541703
Sponsor: Spotlight Medical
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Early Breast Cancer ER-Positive HER2-Negative Breast Cancer

Start date: 2026-04-01
Primary completion: 2027-03-31
Enrollment: 2200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.